Use of anti-CD45 leukocyte antigen antibodies for immunomodulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7160987
SERIAL NO

10102072

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • RESEARCH CORPORATION TECHNOLOGIES, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lazarovits, Andrew I London, CA 5 35
Poppema, Sibrand Bunne, NL 8 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation